SCHEMBL7926560

SCHEMBL7926560

CCOC(OC)Oc1cc2ccc(-c3ccc(O)cc3)cc2cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 9/20 0.45
RARG P13631 7/20 0.45
RARA P10276 4/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
NR1I2 O75469 1/20 0.45
LMNA P02545 1/20 0.45
PGR P06401 1/20 0.45
HSPD1 P10809 1/20 0.45
GOT1 P17174 1/20 0.45
GLRA1 P23415 1/20 0.45
BLM P54132 1/20 0.45
HSPE1 P61604 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
THRB P10828 1/20 0.44
RECQL P46063 1/20 0.44
NR2E1 Q9Y466 1/20 0.44
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7920732 0.90 RARB (0.43) RARBRARGRARAMEN1KMT2A
SCHEMBL9011095 0.89 RARB (0.42) RARBRARGRARAMEN1KMT2A
SCHEMBL7920671 0.89 MEN1 (0.47) RARBRARGRARAMEN1KMT2A
SCHEMBL1361021 0.89 MEN1 (0.58) RARBRARGRARAMEN1KMT2A
SCHEMBL7929375 0.89 RARB (0.51) RARBRARGRARAMEN1KMT2A
SCHEMBL7926531 0.89 RARB (0.46) RARBRARGRARAMEN1KMT2A
SCHEMBL7929427 0.88 RARB (0.50) RARBRARGRARAMEN1KMT2A
SCHEMBL7927675 0.88 RARB (0.50) RARBRARGRARAMEN1KMT2A
SCHEMBL7920886 0.88 RARB (0.43) RARBRARGRARAMEN1KMT2A
SCHEMBL8458440 0.87 RARB (0.40) RARBRARGRARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0740937-A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1996-11-06 EP claimed
US-6225328-B1 FOR THERAPY OF DISORDERS OR AILMENTS RELATED TO AN OVERREGULATION OF RETINOIC ACID RECEPTORS AND/OR TO HYPERVIAMINOSIS A CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-05-01 US disclosed
EP-0740937-A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1996-11-06 EP disclosed